Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Axsome Therapeutics Stock Cratered in August

TheMotleyFool

0 0

Why Axsome Therapeutics Stock Cratered in AugustPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

Axsome Therapeutics (NASDAQ: AXSM), a clinical-stage biotech focused on the development of drugs for central nervous system disorders, had a seriously rough August. The biotech's shares slipped by an eye-popping 47.1% last month, according to data provided by S&P Global Market Intelligence.

Axsome's stock cratered last month for two interrelated reasons:

Image source: Getty Images.

Source Fool.com

Like: 0

AXSM

Teilen